Company intelligence / Profile preview

Yaohai Ningkang

Taizhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Yaohai Ningkang is a specialized Contract Development and Manufacturing Organization (CDMO) based in China, focusing on microbial expression systems and advanced biologics. The company provides comprehensive services for recombinant proteins, plasmid DNA, and mRNA-based products, covering process development, analytical testing, and GMP-compliant manufacturing. As a key entity within the Yaohai Bio-Tech ecosystem, it leverages extensive expertise in E. coli and yeast-based fermentation to support global biopharmaceutical clients. The company aims to accelerate the translation of innovative therapies from early-stage R&D through to commercial production.

Modalities: Recombinant proteinmRNA-based drugsPlasmid DNABiologicVaccine
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Yaohai Ningkang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yaohai Ningkang.

Explore the full profile